Tower Research Capital (TRC)’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $295K | Buy |
|
|||||
|
2025
Q1 | $11.2K | Sell |
|
|||||
|
2024
Q4 | $284K | Buy |
|
|||||
|
2024
Q3 | $16.2K | Sell |
|
|||||
|
2024
Q2 | $509K | Buy |
|
|||||
|
2024
Q1 | $9.31K | Sell |
|
|||||
|
2023
Q4 | $270K | Buy |
|
|||||
|
2023
Q3 | $129K | Buy |
|
|||||
|
2023
Q2 | $86.1K | Buy |
|
|||||
|
2023
Q1 | $38K | Sell |
|
|||||
|
2022
Q4 | $19K | Sell |
|
|||||
|
2022
Q3 | $229K | Sell |
|
|||||
|
2022
Q2 | $401K | Buy |
|
|||||
|
2022
Q1 | $146K | Sell |
|
|||||
|
2021
Q4 | $302K | Sell |
|
|||||
|
2021
Q3 | $215K | Buy |
|
|||||
|
2021
Q2 | $92K | Buy |
|
|||||
|
2021
Q1 | $40K | Sell |
|
|||||
|
2020
Q4 | $225K | Buy |
|
|||||
|
2020
Q3 | $26K | Sell |
|
|||||
|
2020
Q2 | $51K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $20K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $1K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $48K | Buy |
|
|||||
|
2018
Q3 | $1K | Sell |
|
|||||
|
2018
Q2 | $7K | Sell |
|
|||||
|
2018
Q1 | $11K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $31K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $9K | Buy |
|